WHO ICTRP trial
The observation on the effect of low-dose rosalastat combined with recombinant…
ChiCTR2300071419 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300071419 |
|---|---|
| Public title | The observation on the effect of low-dose rosalastat combined with recombinant human erythropoietin on the improvement of moderate renal anemia in patients with chronic renal failure |
| Scientific title | The observation on the effect of low-dose rosalastat combined with recombinant human erythropoietin on the improvement of moderate renal anemia in patients with chronic renal failure |
| Primary sponsor | Zhejiang Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | renal anemia |
| Interventions | Roxadustat group:No;ESA group:No;ESA + Roxadustat:No |
| Registration date | May 15, 2023 |
| Target size | Roxadustat group:52;ESA group:52;ESA + Roxadustat:52 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: